Population
1,642 consecutive patients who received an implantable cardioverter defibrillator and underwent…
Design
Cohort
Authors
Loading...
May support selective DFT testing; leaves open prospective validation of the proposed risk tool.
The EF-SAGA risk score identifies patients at high risk for elevated defibrillation thresholds, suggesting routine testing may be safely avoided in primary prevention patients with LVEF > 20%.
Shih et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: